Skip to main content
. 2012 Sep 3;4(5):790–794. doi: 10.3892/etm.2012.694

Table V.

Eight patients with KRAS mutations in both the primary tumour tissue and peripheral blood samples.

Patient Gender Age Mutation site Differentiation T N Stage
1 Female 71 Gly13Asp Moderately 3 0 IIA
2 Female 81 Gly12Val Moderately 3 0 IIA
3 Male 65 Gly12Asp Well 4 0 IIB
4 Male 72 Gly12Ser Moderately 4 1 IIIB
5 Female 51 Gly13Asp Moderately 3 2 IIIC
6 Female 78 Gly12Val Moderately 3 2 IIIC
7 Female 72 Gly12Ser Well 3 2 IV
8 Male 74 Gly12Cys Moderately 3 1 IV